An interferon is a group of host-specific glycoproteins secreted by cells in response to virus infections or other factors. As a cytokine, it can defend against a wide variety of viruses by stimulating the synthesis of new effector proteins in interaction with the receptors on uninfected cells though it cannot directly kill or inhibit the viruses in cells. Besides, it can achieve immunoregulation and anti-cancer effects by enhancing the viability of lymphocytes, macrophages and natural killer cells.By the End of 2018, More than 90 Million People in China were Infected with Hepatitis B Virus and 8 Million Carried Hepatitis C Virus
In 1986, Intron A, the world's first Recombinant Human Interferon a2b, was launched by Schering Plough that was later acquired by MSD, and approved by the FDA to be used for the treatment of chronic hepatitis B. In 1997, Tianjin Sinobioway Biomedicine Co., Ltd.'s Recombinant Human Interferon a2b was approved to be sold in China, followed by the counterparts of Anhui Anke Biotechnology (Group) Co., Ltd., Zhejiang Beisheng Medicine Industry Hansheng Pharmaceutical Co., Ltd. and Schering-Plough that was approved in 1998, 1999 and 2007 respectively.
Recombinant Human Interferon a2b has been approved by the China Food and Drug Administration to be sold in the dosage forms of freeze-dried powder injection, injection, suppository, cream (ointment), eye drops, etc. The main indications include acute and chronic viral hepatitis infections (hepatitis B and hepatitis C), condyloma acuminatum, hairy cell leukemia, etc. and vary among dosage forms.
The researcher estimates that by the end of 2018, more than 90 million people in China were infected with hepatitis B virus and 8 million carried hepatitis C virus. With the increasing incidence of herpes, 80%-90% of the Chinese population are infected with herpes zoster virus, and 30% of the infected may develop chickenpox, and the rest 70% will be attacked by herpes zoster when they are weak. Furthermore, over 40% of married women in China are suffering from cervical erosion.
According to market research, the sales value of Recombinant Human Interferon a2b showed an upward trend after the drug was launched in China, reaching about CNY 271 million in 2017. The injections, capsules and gels take up a large market share, with Shanghai Huaxin High Biotechnology Inc., Zhaoke Pharmaceutical (Hefei) Co. Ltd. and Schering-Plough as the top market players by sales value.
Topics Covered:
- Status of China's Recombinant Human Interferon a2b market
- Major manufacturers of Recombinant Human Interferon a2b in China
- Prices of Recombinant Human Interferon a2b in China
- Major factors influencing the development of Recombinant Human Interferon a2b in China
- Prospect of China's Recombinant Human Interferon a2b market from 2018 to 2022
Table of Contents
Samples
LOADING...
Companies Mentioned
- Anhui Anke Biotechnology (Group) Co., Ltd.
- Beijing Kawin Technology Share-Holding Co., Ltd. (Kawin Yisheng)
- Schering-Plough (Intron A)
- Shanghai Huaxin High Biotechnology Inc. (Xinhuanuo)
- Tianjin Sinobioway Biomedicine Co., Ltd. (Alfaron)
- Zhaoke Pharmaceutical (Hefei) Co. Ltd. (Yallaferon)
- Zhejiang Beisheng Medicine Industry Hansheng Pharmaceutical Co., Ltd.
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
